Under-representation of the elderly in cancer clinical trials
- PMID: 21135763
- DOI: 10.12968/hmed.2010.71.12.678
Under-representation of the elderly in cancer clinical trials
Abstract
Cancer predominantly affects the elderly, but those over 65 years of age are significantly and consistently under-represented in clinical trials of potential new treatments. How important is this to cancer care in the elderly, are there identifiable reasons for the disparity and can anything be done to redress the imbalance?
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
